Acinic cell carcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
| (One intermediate revision by one other user not shown) | |||
| Line 6: | Line 6: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Low grade, low stage (I and II) and adequately resected [[acinic cell carcinoma]] are not considered for any further therapy, as their prognosis is excellent with surgery alone. additional medical therapies are:<ref name="Vander PoortenMarchal2010">{{cite journal|last1=Vander Poorten|first1=Vincent L. M.|last2=Marchal|first2=Francis|last3=Nuyts|first3=Sandra|last4=Clement|first4=Paul M. J.|title=Parotid carcinoma: Current diagnostic workup and treatment|journal=Indian Journal of Surgical Oncology|volume=1|issue=2|year=2010|pages=96–111|issn=0975-7651|doi=10.1007/s13193-010-0022-x}}</ref> | |||
* Low grade, low stage (I and II) and adequately resected [[acinic cell carcinoma]] are not considered for any further therapy, as their [[prognosis]] is excellent with surgery alone. additional medical therapies are:<ref name="Vander PoortenMarchal2010">{{cite journal|last1=Vander Poorten|first1=Vincent L. M.|last2=Marchal|first2=Francis|last3=Nuyts|first3=Sandra|last4=Clement|first4=Paul M. J.|title=Parotid carcinoma: Current diagnostic workup and treatment|journal=Indian Journal of Surgical Oncology|volume=1|issue=2|year=2010|pages=96–111|issn=0975-7651|doi=10.1007/s13193-010-0022-x}}</ref> | |||
=== Radiotherapy === | === Radiotherapy === | ||
Criteria for additional [[radiotherapy]] | Criteria for additional [[radiotherapy]] of [[acinic cell carcinoma]] does not differ with other [[salivary gland]] [[Carcinoma|carcinomas]] and include:<ref name="PatelSanghvi2013">{{cite journal|last1=Patel|first1=Neal R.|last2=Sanghvi|first2=Saurin|last3=Khan|first3=Mohemmed N.|last4=Husain|first4=Qasim|last5=Baredes|first5=Soly|last6=Eloy|first6=Jean Anderson|title=Demographic trends and disease‐specific survival in salivary acinic cell carcinoma: An analysis of 1129 cases|journal=The Laryngoscope|volume=124|issue=1|year=2013|pages=172–178|issn=0023-852X|doi=10.1002/lary.24231}}</ref> | ||
* Salvage surgery for recurrent disease | *[[Salvage therapy|Salvage]] surgery for recurrent disease | ||
* Advanced [[TNM classification|T-classification]](T3/T4) | * Advanced [[TNM classification|T-classification]](T3/T4) | ||
* Positive surgical lymph margins | * Positive surgical lymph margins | ||
* Pathologically positive cervical lymph node | * Pathologically positive [[Cervical lymph nodes|cervical lymph node]] | ||
* [[Perineural fibroma|Perineural]] invasion | * [[Perineural fibroma|Perineural]] [[invasion]] | ||
* High grade/Highly | * High grade/Highly proliferative tumors. | ||
Conversely Biron et al <ref name="BironLentsch2015">{{cite journal|last1=Biron|first1=Vincent L.|last2=Lentsch|first2=Eric J.|last3=Gerry|first3=Daniel R.|last4=Bewley|first4=Arnaud F.|title=Factors influencing survival in acinic cell carcinoma: A retrospective survival analysis of 2061 patients|journal=Head & Neck|volume=37|issue=6|year=2015|pages=870–877|issn=10433074|doi=10.1002/hed.23686}}</ref> | Conversely Biron et al suggest that '[[radiotherapy]] probably is not effective in [[Acinic cell carcinoma (patient information)|acinic cell carcinoma]].<ref name="BironLentsch2015">{{cite journal|last1=Biron|first1=Vincent L.|last2=Lentsch|first2=Eric J.|last3=Gerry|first3=Daniel R.|last4=Bewley|first4=Arnaud F.|title=Factors influencing survival in acinic cell carcinoma: A retrospective survival analysis of 2061 patients|journal=Head & Neck|volume=37|issue=6|year=2015|pages=870–877|issn=10433074|doi=10.1002/hed.23686}}</ref> | ||
=== Chemotherapy === | === Chemotherapy === | ||
* There is insufficient information regarding [[chemotherapy]] in acinic cell carcinoma.<ref name="Vander PoortenTriantafyllou2015">{{cite journal|last1=Vander Poorten|first1=V.|last2=Triantafyllou|first2=A.|last3=Thompson|first3=L. D. R.|last4=Bishop|first4=J.|last5=Hauben|first5=E.|last6=Hunt|first6=J.|last7=Skalova|first7=A.|last8=Stenman|first8=G.|last9=Takes|first9=R. P.|last10=Gnepp|first10=D. R.|last11=Hellquist|first11=H.|last12=Wenig|first12=B.|last13=Bell|first13=D.|last14=Rinaldo|first14=A.|last15=Ferlito|first15=A.|title=Salivary acinic cell carcinoma: reappraisal and update|journal=European Archives of Oto-Rhino-Laryngology|volume=273|issue=11|year=2015|pages=3511–3531|issn=0937-4477|doi=10.1007/s00405-015-3855-7}}</ref> | * There is insufficient information regarding [[chemotherapy]] in acinic cell carcinoma.<ref name="Vander PoortenTriantafyllou2015">{{cite journal|last1=Vander Poorten|first1=V.|last2=Triantafyllou|first2=A.|last3=Thompson|first3=L. D. R.|last4=Bishop|first4=J.|last5=Hauben|first5=E.|last6=Hunt|first6=J.|last7=Skalova|first7=A.|last8=Stenman|first8=G.|last9=Takes|first9=R. P.|last10=Gnepp|first10=D. R.|last11=Hellquist|first11=H.|last12=Wenig|first12=B.|last13=Bell|first13=D.|last14=Rinaldo|first14=A.|last15=Ferlito|first15=A.|title=Salivary acinic cell carcinoma: reappraisal and update|journal=European Archives of Oto-Rhino-Laryngology|volume=273|issue=11|year=2015|pages=3511–3531|issn=0937-4477|doi=10.1007/s00405-015-3855-7}}</ref> | ||
* Some have suggested of positive effects of [[mTOR]] inhibitors due to [[acinic cell carcinoma]], but no specific chemotherapy regimen have been currently approved. | * Some have suggested of positive effects of [[mTOR]] inhibitors due to [[acinic cell carcinoma]], but no specific [[chemotherapy]] regimen have been currently approved. | ||
* Observation of distant metastasis with a rate of 1 in 5 indicate the need for developing | * Observation of distant [[metastasis]] with a rate of 1 in 5 indicate the need for developing such regimen. | ||
==References== | ==References== | ||
Latest revision as of 13:49, 4 October 2019
|
Acinic cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Acinic cell carcinoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Acinic cell carcinoma medical therapy |
|
Risk calculators and risk factors for Acinic cell carcinoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Low grade, low stage (I and II) and adequately resected acinic cell carcinoma are not considered for any further therapy, as their prognosis is excellent with surgery alone. Criteria for additional radiotherapy of acinic cell carcinoma does not differ with other salivary gland carcinomas. There is insufficient information regarding chemotherapy in acinic cell carcinoma. Observation of distant metastasis with a rate of 1 in 5 indicate the need for developing such regimen.
Medical Therapy
- Low grade, low stage (I and II) and adequately resected acinic cell carcinoma are not considered for any further therapy, as their prognosis is excellent with surgery alone. additional medical therapies are:[1]
Radiotherapy
Criteria for additional radiotherapy of acinic cell carcinoma does not differ with other salivary gland carcinomas and include:[2]
- Salvage surgery for recurrent disease
- Advanced T-classification(T3/T4)
- Positive surgical lymph margins
- Pathologically positive cervical lymph node
- Perineural invasion
- High grade/Highly proliferative tumors.
Conversely Biron et al suggest that 'radiotherapy probably is not effective in acinic cell carcinoma.[3]
Chemotherapy
- There is insufficient information regarding chemotherapy in acinic cell carcinoma.[4]
- Some have suggested of positive effects of mTOR inhibitors due to acinic cell carcinoma, but no specific chemotherapy regimen have been currently approved.
- Observation of distant metastasis with a rate of 1 in 5 indicate the need for developing such regimen.
References
- ↑ Vander Poorten, Vincent L. M.; Marchal, Francis; Nuyts, Sandra; Clement, Paul M. J. (2010). "Parotid carcinoma: Current diagnostic workup and treatment". Indian Journal of Surgical Oncology. 1 (2): 96–111. doi:10.1007/s13193-010-0022-x. ISSN 0975-7651.
- ↑ Patel, Neal R.; Sanghvi, Saurin; Khan, Mohemmed N.; Husain, Qasim; Baredes, Soly; Eloy, Jean Anderson (2013). "Demographic trends and disease‐specific survival in salivary acinic cell carcinoma: An analysis of 1129 cases". The Laryngoscope. 124 (1): 172–178. doi:10.1002/lary.24231. ISSN 0023-852X.
- ↑ Biron, Vincent L.; Lentsch, Eric J.; Gerry, Daniel R.; Bewley, Arnaud F. (2015). "Factors influencing survival in acinic cell carcinoma: A retrospective survival analysis of 2061 patients". Head & Neck. 37 (6): 870–877. doi:10.1002/hed.23686. ISSN 1043-3074.
- ↑ Vander Poorten, V.; Triantafyllou, A.; Thompson, L. D. R.; Bishop, J.; Hauben, E.; Hunt, J.; Skalova, A.; Stenman, G.; Takes, R. P.; Gnepp, D. R.; Hellquist, H.; Wenig, B.; Bell, D.; Rinaldo, A.; Ferlito, A. (2015). "Salivary acinic cell carcinoma: reappraisal and update". European Archives of Oto-Rhino-Laryngology. 273 (11): 3511–3531. doi:10.1007/s00405-015-3855-7. ISSN 0937-4477.